CN114958705A - Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system - Google Patents
Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system Download PDFInfo
- Publication number
- CN114958705A CN114958705A CN202210712627.4A CN202210712627A CN114958705A CN 114958705 A CN114958705 A CN 114958705A CN 202210712627 A CN202210712627 A CN 202210712627A CN 114958705 A CN114958705 A CN 114958705A
- Authority
- CN
- China
- Prior art keywords
- seq
- esar
- escherichia coli
- esai
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 44
- 238000000855 fermentation Methods 0.000 title claims abstract description 26
- 230000004151 fermentation Effects 0.000 title claims abstract description 26
- 241001239379 Calophysus macropterus Species 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title claims abstract description 14
- 230000018612 quorum sensing Effects 0.000 title abstract description 17
- 230000033228 biological regulation Effects 0.000 title abstract description 13
- 108010040721 Flagellin Proteins 0.000 title abstract description 5
- 239000013612 plasmid Substances 0.000 claims abstract description 43
- 241000894006 Bacteria Species 0.000 claims abstract description 41
- 101100445598 Pantoea stewartii subsp. stewartii esaI gene Proteins 0.000 claims abstract description 37
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 17
- 238000010353 genetic engineering Methods 0.000 claims abstract description 12
- 101100389725 Pantoea stewartii subsp. stewartii esaR gene Proteins 0.000 claims description 29
- 108020004414 DNA Proteins 0.000 claims description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 239000012634 fragment Substances 0.000 claims description 26
- 108010048367 enhanced green fluorescent protein Proteins 0.000 claims description 24
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 16
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
- 239000004473 Threonine Substances 0.000 claims description 11
- 229960002898 threonine Drugs 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 238000010367 cloning Methods 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 101150000850 thrC gene Proteins 0.000 claims description 6
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 4
- 108700008625 Reporter Genes Proteins 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 102000003960 Ligases Human genes 0.000 claims description 3
- 108090000364 Ligases Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 3
- 229930003270 Vitamin B Natural products 0.000 claims description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 3
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 3
- SCVOEYLBXCPATR-UHFFFAOYSA-L manganese(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O SCVOEYLBXCPATR-UHFFFAOYSA-L 0.000 claims description 3
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 3
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 3
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000019156 vitamin B Nutrition 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 2
- 238000012408 PCR amplification Methods 0.000 claims description 2
- 108010054624 red fluorescent protein Proteins 0.000 claims description 2
- 238000013518 transcription Methods 0.000 claims description 2
- 230000035897 transcription Effects 0.000 claims description 2
- SURQXAFEQWPFPV-UHFFFAOYSA-L iron(2+) sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+2].[O-]S([O-])(=O)=O SURQXAFEQWPFPV-UHFFFAOYSA-L 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 abstract description 12
- 238000005755 formation reaction Methods 0.000 abstract description 9
- 230000033001 locomotion Effects 0.000 abstract description 8
- 238000000354 decomposition reaction Methods 0.000 abstract description 4
- 238000009792 diffusion process Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 230000003197 catalytic effect Effects 0.000 abstract description 2
- 230000008054 signal transmission Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 description 22
- 101150052329 motA gene Proteins 0.000 description 20
- 238000003752 polymerase chain reaction Methods 0.000 description 19
- 230000001580 bacterial effect Effects 0.000 description 18
- 238000006243 chemical reaction Methods 0.000 description 12
- 238000002474 experimental method Methods 0.000 description 11
- 239000002609 medium Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 9
- 229960000723 ampicillin Drugs 0.000 description 9
- 238000010276 construction Methods 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 238000000137 annealing Methods 0.000 description 6
- 238000001514 detection method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 210000003495 flagella Anatomy 0.000 description 4
- 101150040799 luxI gene Proteins 0.000 description 4
- 101150016512 luxR gene Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000032770 biofilm formation Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- PKFDLKSEZWEFGL-MHARETSRSA-N c-di-GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=C(C(NC(N)=N5)=O)N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 PKFDLKSEZWEFGL-MHARETSRSA-N 0.000 description 3
- 238000003235 crystal violet staining Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000013613 expression plasmid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- XNCMOUSLNOHBKY-UHFFFAOYSA-H iron(3+);trisulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O XNCMOUSLNOHBKY-UHFFFAOYSA-H 0.000 description 2
- 238000004020 luminiscence type Methods 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 101150110871 motB gene Proteins 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000013598 vector Substances 0.000 description 2
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- -1 AAA ion Chemical class 0.000 description 1
- 241000607620 Aliivibrio fischeri Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 102000003505 Myosin Human genes 0.000 description 1
- 108060008487 Myosin Proteins 0.000 description 1
- 241000932831 Pantoea stewartii Species 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 230000008568 cell cell communication Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 101150031647 esaI gene Proteins 0.000 description 1
- 101150009888 esaR gene Proteins 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000001822 immobilized cell Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000008560 physiological behavior Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091006107 transcriptional repressors Proteins 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/10—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a carbohydrate
- C12N11/12—Cellulose or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2477—Hemicellulases not provided in a preceding group
- C12N9/248—Xylanases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03001—Threonine synthase (4.2.3.1)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a method for improving immobilized fermentation of escherichia coli by applying flagellin motA to a quorum sensing dynamic regulation and control system. The Escherichia coli genetic engineering bacteria are pUC19-PJ23119-MCS plasmid containing esaI/R system introduced into Escherichia coli W1688, and the plasmid is combined with motion gene motA. The invention combines the motion gene motA related to colibacillus membrane formation with a quorum sensing system esaI/R for the first time, controls the formation, decomposition and diffusion of the biological membrane through signal transmission among quorum sensing signal molecules, establishes a specific regulation and control mode, accurately regulates and controls the formation process of the biological membrane in the fermentation process, strengthens the formation of the biological membrane in the early and middle stages of the fermentation, weakens the decomposition and diffusion in the later stage of the fermentation, and improves the immobilization efficiency and the catalytic efficiency of the biological membrane.
Description
Technical Field
The invention relates to the field of biology, in particular to a method for improving immobilized fermentation of escherichia coli by applying flagellin motA to a quorum sensing dynamic regulation and control system.
Background
Biofilms (bifilms) are a form of microbial community in nature. The microorganisms gather together and secrete organic substances, such as polysaccharides, to cover the surface thereof, forming a film-like substance. The microorganisms can better adapt to the external environment by forming the colony structure, and resist factors which are not beneficial to survival. In the medical field, the drug resistance of the bacteria is improved because the pathogenic bacteria often form a biological membrane, and the research on the biological membrane lasts for a long time. In the field of industrial fermentation applications, the mechanism of biofilm formation is relatively poorly studied. In particular to the molecular research aiming at the fermentation characteristics of the immobilized cells.
Flagella play an important role in the survival and virulence of many pathogenic bacteria. Bacteria propel themselves using rotating flagella, the ability of which is critical to the survival and pathogenicity of the bacteria, consisting of a long outer filament acting as a propeller, a flexible connection structure, a hook, and a motor embedded in the cell envelope. Unlike other biomacromolecule systems that produce mechanical motion (e.g., myosin in muscle), bacterial flagellar motion does not directly use the energy of ATP hydrolysis. Flagellar rotation is powered by the energy of the electrochemical gradient across the cytoplasm. The bacterial flagella movement serves as a membrane-embedded ion-powered rotary engine consisting of a rotor surrounded by a ring of stator protein complexes (MotAB) powering its rotation. The motor is bidirectional: the chemoattractant signal can cause a conformational change in the rotor, known as "switching," which can result in a change in the direction of rotation of the motor. Each motA motB complex is thought to contain two proton conducting channels, spanning the cytoplasmic membrane.
In the early stages of biofilm development, escherichia coli cells are sessile due to adhesion genes attached to the surface, thus inhibiting flagella synthesis. Several small molecules such as cyclic diguanylic acid (c-di-GMP) are responsible for the transition from a planktonic state to a sessile state. The concentration of c-di-GMP is lower in the locomotor state and increases as the biofilm becomes mature. The motA motB compound plays an important role in the movement of escherichia coli and the irreversible attachment of thalli and the surface.
Quorum Sensing (QS) is a bacterial cell-to-cell communication system, where microorganisms sense changes in the density of bacterial populations through secretion of diffusible small molecule signals, thereby causing coordinated expression of a set of specific genes at the transcriptional level. This communication allows the bacteria to express different physiological behaviors including regulation of bioluminescence, biofilm formation, toxin production, spore formation, and the like.
With the intensive research on quorum sensing action mechanism, the biological characteristic can be used for developing a cell density-dependent self-induced dynamic regulation tool. In E.coli, lacking genes responsible for the synthesis of AHLs with functions similar to LuxI, it is not capable of producing AHL signal molecules by itself, but they encode LuxR homologous proteins and therefore can sense and respond to AHLs produced by other bacteria.
The AHL-mediated quorum sensing systems currently most studied and most widely used are mainly the luxI/luxR system from Vibrio fischeri and the esaI/esaR system from bacterial wilt disease of maize. Among gram-negative bacteria, the QS system, consisting of the luxI/luxR bi-component, is the most widely studied. Whereas the esaI/esaR system is homologous to the luxI/luxR system and originates from the maize pathogen Pantoea stewartii subspecies. Unlike most LuxR homologues, esaR can act as both a transcriptional activator and repressor, independent of whether binding to AHL signaling molecule occurs. In addition, Pesar is a native promoter that is repressed by esaR, and Pesas is a native promoter that is activated by esaR. At low cell densities, the cells produce less AHL signaling molecule and esaR binds to its target DNA sequence (esa box) turning on P esaS Expression of downstream genes, turning off P esaR Expression of a gene downstream of the promoter. At high cell densities, the cells produced more AHL signaling molecules and esaR released esa box binding to AHL, at which time promoter P esaR Is opened and P esaS And closing.
Disclosure of Invention
The purpose of the invention is as follows: the technical problem to be solved by the invention is to provide a genetically engineered Escherichia coli strain aiming at the defects of the prior art.
The technical problem to be solved by the invention is to provide a construction method of the escherichia coli genetic engineering bacteria.
The technical problem to be solved by the invention is to provide the application of the escherichia coli genetic engineering bacteria.
The invention idea is as follows: the esaI/esaR system is homologous with the luxI/luxR system and has a quorum sensing system with a bidirectional regulation function, and the motor gene motA is proved to promote the formation of an escherichia coli biofilm; therefore, the invention selects to utilize the esaI/esaR system and the motA to realize the aim of dynamic regulation.
In order to solve the first technical problem, the invention discloses an escherichia coli genetic engineering bacterium containing quorum sensing dynamic regulation and control biofilm formation, and pUC19-PJ23119-MCS plasmids containing esaI/R systems are introduced into escherichia coli W1688 and combined with a motor gene motA influencing escherichia coli film formation, so that the escherichia coli genetic engineering bacterium is applied to increase of escherichia coli film formation amount, and fermentation efficiency is further increased in immobilized fermentation.
Wherein, the gene contained in the esaI/R system is a transcription regulation factor with the nucleotide sequence respectively shown as SEQ ID NO.1 and SEQ ID NO. 2: esaI, esaR; the nucleotide sequences of the promoter are respectively shown as SEQ ID NO.3 and SEQ ID NO. 4: p esaS 、P esaR-P (ii) a The nucleotide sequences of the reporter genes are respectively shown as SEQ ID NO.5 and SEQ ID NO. 6: red fluorescent protein mCherry, green fluorescent protein EGFP.
Wherein the nucleotide sequence of the motion gene motA is shown as SEQ ID NO. 7.
In order to solve the second technical problem, the invention discloses a construction method of the escherichia coli genetic engineering bacterium, which comprises the following steps:
(1) amplifying to obtain esaI and esaR genes by taking pseudomonas aeruginosa genome DNA as a template; the gene P is synthesized by general biosynthesis esaS 、P esaR-P The PUC19 plasmid is used as a template to obtain P through amplification esaS 、P esaR-P A gene; amplifying by taking a plasmid pET28a-mCherry as a template to obtain an mCheerry gene; amplifying by taking the plasmid pET-28a-EGFP as a template to obtain an EGFP gene;
(2) taking the fragment obtained in the step (1) as a template, and carrying out overlap PCR amplification to obtain an esaI + esaR fragment and P esaS + motA + mCherry fragment, P esaR-P + an EGFP fragment;
(3) cloning the gene fragment obtained in the step (2) between Hind III and Sac I restriction sites of plasmid pUC19-PJ23119-MCS to obtain recombinant plasmid pUC19-PJ23119-MCS-esaI/R, wherein the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 8;
(4) transforming the recombinant plasmid obtained in the step (3) into an escherichia coli T1 competence, and extracting, purifying and recovering the recombinant plasmid from escherichia coli T1;
(5) and (3) transforming the recombinant plasmid extracted in the step (4) into the competence of Escherichia coli W1688 to obtain the Escherichia coli genetic engineering bacteria.
In the step (1), primers for amplifying esaI and esaR genes are esaI-F, esaI-R, esaR-F, esaR-R with nucleotide sequences shown in SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO.14 respectively.
In step (1), P is amplified esaS 、P esaR-P The primers of the gene are P with nucleotide sequences shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO.18 respectively esaS -F、P esaS -R、P esaR-P -F、P esaR-P -R。
In the step (1), primers for amplifying mCherry and EGFP genes are mChery-F, mCherry-R, EGFP-F, EGFP-R with nucleotide sequences shown as SEQ ID No.19, SEQ ID No.20, SEQ ID No.21 and SEQ ID No.22 respectively.
In order to solve the third technical problem, the invention discloses application of the large Escherichia coli genetic engineering bacteria in L-threonine production.
The application comprises the steps of replacing threonine synthetase thrC with a nucleotide sequence shown as SEQ ID No.23 to the position of an EGFP gene in the large escherichia coli genetic engineering bacteria, inoculating the bacteria into an LB culture medium for culture to obtain a bacterial liquid, diluting the bacterial liquid until OD is 0.05-0.15, and then inoculating the bacterial liquid into a fermentation culture medium containing an immobilized carrier for immobilized fermentation to produce xylanase.
Wherein the fermentation medium comprises 30g/L of glucose, 0.8g/L of sodium chloride, 20-22g/L of ammonium sulfate, 2g/L of anhydrous potassium dihydrogen phosphate, 0.8g/L of magnesium sulfate heptahydrate, 0.02g/L of manganese sulfate pentahydrate, 0.02g/L of ferric sulfate heptahydrate, 10.002g/L of vitamin B, 1g/L of yeast powder and 15-30g/L of calcium carbonate.
Wherein the immobilized carrier is cotton fiber.
Wherein the dosage of the immobilized carrier is 3-7 g/100mL of fermentation medium.
Has the advantages that: compared with the prior art, the invention has the following advantages:
the invention combines the motion gene motA related to colibacillus membrane formation with a quorum sensing system esaI/R for the first time, controls the formation, decomposition and diffusion of the biological membrane through signal transmission among quorum sensing signal molecules, establishes a specific regulation and control mode, accurately regulates and controls the formation process of the biological membrane in the fermentation process, strengthens the formation of the biological membrane in the early and middle stages of the fermentation, weakens the decomposition and diffusion in the later stage of the fermentation, and improves the immobilization efficiency and the catalytic efficiency of the biological membrane.
Drawings
The foregoing and/or other advantages of the invention will become further apparent from the following detailed description of the invention when taken in conjunction with the accompanying drawings.
FIG. 1 shows motA, esaI, esaR, P in example 1 esaS 、P esaR-P Agarose gel electrophoresis of genes mCherry and EGFP.
FIG. 2 depicts the esaI + esaR fragment, P, after OVERLAP in example 1 esaS + motA + mCherry fragment and P esaR-P Agarose gel electrophoresis of the P + EGFP fragment.
FIG. 3 is a schematic diagram of the construction of a recombinant expression plasmid in example 1.
FIG. 4 is a PCR scheme of plasmid-transformed colonies in example 1.
FIG. 5 is a graph showing the results of fluorescence microscopy in example 2.
FIG. 6 is a graph showing the results of fluorescence intensity detection by the microplate reader in example 3.
FIG. 7 is a graph showing the results of the crystal violet staining experiment in example 4.
FIG. 8 is a graph showing the results of L-threonine production in example 5.
Detailed Description
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
In the following embodiment, the Escherichia coli strain selected for use in the present invention is W1688, and Pseudomonas aeruginosa strain selected for use in the present invention is ATCC 15692.
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
Example 1: construction of the target Strain
First, amplification of target Gene
(1) Using the original genome of escherichia coli as a template, and using a common PCR (polymerase chain reaction) to amplify by using motA-F, motA-R (sequences are respectively shown as SEQ ID NO.9 and SEQ ID NO. 10) as a primer to obtain motA; using pseudomonas aeruginosa genome DNA as a template, and using common PCR to amplify by using esaI-F, esaI-R, esaR-F, esaR-R (sequences are respectively shown as SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO. 14) as a primer to obtain esaI and esaR; the gene P is synthesized by general biosynthesis esaS 、P esaR-P The pUC19 plasmid was used as a template, and P was used as a template in the conventional PCR esaS -F、P esaS -R、P esaR-P -F、P esaR-P -R (the sequences are respectively shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO. 18) is used as a primer for amplification to obtain P esaS 、P esaR-P A gene; using plasmid pET28a-mCherry as a template, and using a common PCR to amplify by using mCherry-F, mCherry-R (sequences are respectively shown as SEQ ID NO.19 and SEQ ID NO. 20) as a primer to obtain a reporter gene mCheerry; the reporter gene EGFP is obtained by using plasmid pET-28a-EGFP as a template and EGFP-F, EGFP-R (sequences are respectively shown as SEQ ID NO.21 and SEQ ID NO. 22) as a primer through common PCR (polymerase chain reaction).
The PCR reaction system is shown in Table 1 below, and the reaction conditions are as follows: pre-denaturation at 95 ℃ for 4 min; denaturation at 94 ℃ for 10 s; annealing at 60 ℃ for 30 s; extending for 2min at 68 ℃; the three steps of denaturation, annealing and extension are circulated for 35 times; further extension was carried out at 68 ℃ for 10 min. Wherein the annealing temperature depends on the Tm value of the primer, and the extension time at 68 ℃ depends on the length of the amplified fragment (1 kb/min). After the PCR is finished, the products are subjected to agarose gel electrophoresis, as shown in figure 1, and the target genes motA, esaI, esaR and P are obtained by cutting and recovering the gel esaS 、P esaR-P 、mCherry、EGFP。
TABLE 1 PCR reaction System
(2) Using the esaI gene and the esaR gene obtained in the step (1) as templates, using esaI-F as an upper primer and esaR-R as a lower primer, and amplifying by using an overlap PCR technology to obtain an esaI + esaR fragment; with P obtained in step (1) esaS The gene, motA gene and mCherry gene are used as templates and P is used esaS F is an upper primer, mchery-R is a lower primer, and P is obtained by applying overlap PCR technology to amplify esaS + motA + mCherry fragment; with P obtained in step (1) esaR-P Gene and EGFP gene as template, using P esaR-P F is an upper primer, EGFP-R is a lower primer, and P is obtained by amplification by using overlap PCR technology esaR-P + an EGFP fragment;
the PCR reaction system is shown in Table 3 below, and the reaction conditions are as follows: pre-denaturation at 95 ℃ for 4 min; denaturation at 94 ℃ for 10 s; annealing at 60 ℃ for 30 s; extending for 2min at 68 ℃; three steps of denaturation, annealing and extension are cycled for 30 times; further extension was carried out at 68 ℃ for 10 min. Wherein the annealing temperature depends on the Tm value of the primer, and the extension time at 68 ℃ depends on the length of the amplified fragment (1 kb/min). After the PCR was completed, the product was subjected to agarose gel electrophoresis, see FIG. 2, and the three fragment modules esaI + esaR fragment and P were recovered by cutting the gel esaS + motA + mCherry fragment and P esaR-P + EGFP fragment.
TABLE 2 PCR reaction System
Second, construction of recombinant plasmid
(1) Plasmid extracting body
(2) Linearization of vectors
To introduce a target geneFragment (esaI + esaR, P) esaS + mCherry and P esaR-P + EGFP) was ligated to plasmid pUC19-PJ23119-MCS, which was digested in a double digestion reaction system (20. mu.L) of 0.1% BSA 2. mu.L, 1. mu.M buffer 2. mu.L, 0.5. mu.L each of HindIII and SacI enzymes (from TAKARA), plasmid pUC19-PJ23119-MCS 10. mu.L, sterile water 5. mu.L. The enzyme digestion reaction is carried out for 2h at 37 ℃. And (4) carrying out gel recovery after enzyme digestion for subsequent experiments.
Wherein, the buffer: 10 × Loading buffer: 0.9% SDS, 50% glycocol, 0.05% Bromophenol Blue;
Definition of enzyme activity: the reaction was carried out at 37 ℃ for 1 hour in 50. mu.L of the reaction solution, and the amount of the enzyme that completely decomposed 1. mu.g of lambda.DNA was defined as 1 activity unit (U).
(3) Construction of plasmid pUC19-PJ23119-MCS-esaI/R
The three fragments (esaI + esaR, P) esaS + mCherry and P esaR-P + EGFP) was ligated to the purified linear vector following the procedures described in the instructions for the multicegment one-step cloning of the enzyme by NEB to obtain the recombinant plasmid pUC19-PJ23119-MCS-esaI/R (SEQ ID NO. 8). The one-step cloning reaction system was as shown in Table 3, and was immediately ice-cooled for 5 minutes after being water-bathed at 50 ℃ for 15 minutes and stored at-20 ℃. A schematic diagram of the construction of the recombinant expression plasmid is shown in FIG. 3.
TABLE 3 Multi-fragment one-step cloning reaction System
Wherein the plasmid pUC19-PJ23119-MCS after double digestion, the purified gene fragment esaI + esaR and the purified geneFragment P esaS + motA + mCherry, purified gene fragment P esaR-P + EGFP concentration 100 ng/. mu.l.
(4) Transformation and selection of recombinant plasmids
T1 (purchased from all-gold) competent cells were thawed to liquid state on ice, and competent cells and recombinant plasmid pUC19-PJ23119-MCS-esaI/R at a ratio of 10:1v/v were added to a pre-cooled centrifuge tube. Standing on ice for 30min, and performing heat shock in 42 deg.C water bath for 90 s. The ice box was cooled for 3 minutes, added with 1mL LB at 37 degrees C, 200rpm culture for 1 hours, centrifugal removal of most of the supernatant heavy suspension bacteria liquid and ampicillin resistance plate. After overnight incubation in an incubator at 37 ℃, single spots on the plates were picked, 100. mu.g/ml ampicillin resistance in the shake tube was added, and then the plasmid pUC19-PJ23119-MCS-esaI/R was extracted for sequencing validation.
Third, construction of recombinant strains
After the recombinant plasmid is successfully verified, a system strain containing esaI/R is constructed and named as Escherichia coli W1688-P. The successfully verified recombinant plasmid is transferred into the escherichia coli W1688 competence by the same transformation method, and a single colony is picked for colony PCR verification. The results of colony PCR experiments are shown in FIG. 4, and it can be seen that the transformation was successful.
Example 2: performing fluorescence microscope observation on the original bacterium W1688 and the modified bacterium W1688-P
(1) Glycerol bacterium WT (original bacterium W1688) and modified bacterium W1688-P (the strain containing esaI/R system constructed in example 1) were each added in an amount of 100. mu.L to a sterilized LB liquid medium of 5mL overnight for culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterial liquid obtained in the step (1) to 100mL of LB liquid medium (ampicillin resistance, 100. mu.g/mL; 3mL of 1M L-arabinose was added when appropriate) and continuing the culture at 37 ℃ and 220rpm for 13 hours;
(3) and (3) directly observing the cultured bacterial liquid in the step (2) under a fluorescence microscope after sampling, wherein the fluorescence microscope result is shown in figure 5, which shows that the original transformed bacterium has no luminescence, and the transformed bacterium has luminescence, and shows that the esaI/R system of the transformed bacterium W1688-P is constructed without errors.
Example 3: fluorescence intensity detection experiment of enzyme labeling instrument for transformed bacterium W1688-P
(1) Since the original bacterium W1688 did not emit light in the above fluorescence microscope observation, only the modified bacterium was detected in the fluorescence intensity detection experiment. The transformed strain W1688-P (the strain containing the esaI/R system constructed in example 1) was added to a sterilized 5mL LB liquid medium in an amount of 100. mu.L for overnight culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterial liquid obtained in the step (1) to 100mL of LB liquid medium (ampicillin resistance, 100 mu g/mL), continuously culturing at 37 ℃ and 220rpm, and taking samples every 4 hours for 48 hours;
(3) the well-taken sample is diluted by 20 times by PBS buffer solution, 200 mu L of the diluted sample is added into a 96-well plate, and detection is carried out by a microplate reader at different wavelengths respectively: detecting the green fluorescence intensity of the excitation wavelength of 485nm and the emission wavelength of 528nm, and detecting the red fluorescence intensity of the excitation wavelength of 587nm and the emission wavelength of 610 nm. The fluorescence intensity is shown in fig. 6, the red fluorescence (mCherry) is stronger in the early stage, the green fluorescence (EGFP) is stronger in the later stage, and the fluorescent intensity accords with the process of our esaI/R system and the experimental design concept, so that the next step of application can be carried out.
Example 4: biofilm crystal violet staining experiment
The threonine synthetase thrC (derived from Escherichia coli and having a nucleotide sequence shown in SEQ ID NO.23) catalyzing homoserine to synthesize L-threonine in the L-threonine metabolic pathway is replaced to the position of EGFP gene.
Alternatively, the recombinant plasmid EGFP is cut off by using an enzymatic cleavage site and thrC is ligated by performing one-step cloning with the one-step cloning kit C112 of Novozam, which is similar to the step (3) of example 1, thereby obtaining the strain W1688-P-thrC.
Simultaneously, a strain W1688-thrC containing thrC gene only is constructed (the method is the same as the above, and the used plasmid is an empty plasmid PUC19 without esaI/R system).
(1) Glycerol bacterium WT (original bacterium W1688), modified bacterium W1688-P (the strain containing esaI/R system constructed in example 1), W1688-thrC and W1688-P-thrC were each added in 100. mu.L of each of them to a sterilized 5mL LB liquid medium for overnight culture (ampicillin resistance, 100. mu.g/mL), and activated;
(2) according to the volume ratio of 1: 10, transferring the activated bacterium liquid obtained in the step (1) to 100mL of LB liquid culture medium, and continuously culturing at 37 ℃ and 220rpm until the OD600 value of the bacterium liquid is between 0.8 and 1.2;
(3) measuring the absorbance value of 2mL of bacterial liquid under OD600, and diluting the bacterial liquid by using a sterilized LB liquid culture medium to enable the OD600 of the diluted bacterial liquid to be 1;
(4) adding 200 mu L of diluted bacterial liquid into a 96-well plate, using a liquid culture medium as a reference, and culturing at 37 ℃ for 12h, 24h and 36 h;
(5) pouring out the bacterial liquid in the 96-well plate, taking 200 mu L of 0.01M PBS buffer solution to wash for 2-3 times, and patting dry; adding 200 μ L paraformaldehyde fixing solution, fixing for 15min, pouring off, and air drying. Adding 200 μ L of 1% crystal violet solution into 96-well plate, staining for 10-20min, washing with PBS buffer solution for 2-3 times, and drying; adding 200 μ L glacial acetic acid into 96-well plate to dissolve the biofilm, gently shaking for 40min, measuring OD570nm biofilm yield, and taking average value. The crystal violet staining experiment result is shown in figure 7, which shows that the modified strain W1688-P-thrC biofilm is increased obviously, and the biofilm immobilization fermentation experiment can be carried out.
Example 5: the respective bacteria are used for producing L-threonine by immobilized fermentation
Fermentation medium: 30g/L of glucose, 0.8g/L of sodium chloride, 20g/L of ammonium sulfate, 2g/L of anhydrous potassium dihydrogen phosphate, 0.8g/L of magnesium sulfate heptahydrate, 0.02g/L of manganese sulfate pentahydrate, 0.02g/L of ferric sulfate heptahydrate, 10.002g/L of vitamin B, 1g/L of yeast powder and 15g/L of calcium carbonate.
Fermentation: w1688, W1688-P, W1688-thrC, and W1688-P-thrC were removed from the freezer at-80 ℃ and 5mL of LB medium was prepared in tubes, one of which contained 100. mu.g/mL ampicillin in a bottle with an inoculum size of 1%. Culturing in a shaker at 37 deg.C for 12h at 200rpm to obtain bacterial liquid.
The resulting bacterial solution was diluted to OD 0.1 and inoculated into 100mL of a fermentation medium (5 g of cotton fibers cut into squares were placed in the medium in advance), and cultured in a shaker at 37 ℃ for 36 hours at a rotation speed of 200 and 220 rpm.
The detection method comprises the following steps: the L-threonine concentration was measured by high performance liquid chromatography and UV detector (ultraviolet 254nm), using a Sepax AAA ion exclusion column (250X 4.6mm), at 36 ℃ with 0.1mol/L sodium acetate and 80% acetonitrile as mobile phases, at a feed rate of 5. mu.L each time and a running time of 50min, the peak areas of the different samples were determined, and the contents were calculated using the standard solution curve as a reference. The L-threonine content determination experiment result is shown in FIG. 8, the original bacterium yield is 10.5g/L, the modified bacterium yield is 13.5g/L, and the modified bacterium yield is improved by 1.29 times.
The invention provides an escherichia coli genetic engineering bacterium containing an esaI/R quorum sensing system, and a construction method and application thereof, the above description is only a preferred embodiment of the invention, and it should be noted that, for a person skilled in the art, a plurality of improvements and modifications can be made without departing from the principle of the invention, and these improvements and modifications should also be regarded as the protection scope of the invention. All the components not specified in the present embodiment can be realized by the prior art.
Sequence listing
<110> Nanjing university of industry
<120> method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system
<160> 23
<170> SIPOSequenceListing 1.0
<210> 1
<211> 606
<212> DNA
<213> esaI
<400> 1
atgatcgtac aaattggtcg gcgcgaagag ttcgataaaa aactgctggg cgagatgcac 60
aagttgcgtg ctcaagtgtt caaggagcgc aaaggctggg acgttagtgt catcgacgag 120
atggaaatcg atggttatga cgcactcagt ccttattaca tgttgatcca ggaagatact 180
cctgaagccc aggttttcgg ttgctggcga attctcgata ccactggccc ctacatgctg 240
aagaacacct tcccggagct tctgcacggc aaggaagcgc cttgctcgcc gcacatctgg 300
gaactcagcc gtttcgccat caactctgga cagaaaggct cgctgggctt ttccgactgt 360
acgctggagg cgatgcgcgc gctggcccgc tacagcctgc agaacgacat ccagacgctg 420
gtgacggtaa ccaccgtagg cgtggagaag atgatgatcc gtgccggcct ggacgtatcg 480
cgcttcggtc cgcacctgaa gatcggcatc gagcgcgcgg tggccttgcg catcgaactc 540
aatgccaaga cccagatcgc gctttacggg ggagtgctgg tggaacagcg actggcggtt 600
tcatga 606
<210> 2
<211> 720
<212> DNA
<213> esaR
<400> 2
atggccttgg ttgacggttt tcttgagctg gaacgctcaa gtggaaaatt ggagtggagc 60
gccatcctgc agaagatggc gagcgacctt ggattctcga agatcctgtt cggcctgttg 120
cctaaggaca gccaggacta cgagaacgcc ttcatcgtcg gcaactaccc ggccgcctgg 180
cgcgagcatt acgaccgggc tggctacgcg cgggtcgacc cgacggtcag tcactgtacc 240
cagagcgtac tgccgatttt ctgggaaccg tccatctacc agacgcgaaa gcagcacgag 300
ttcttcgagg aagcctcggc cgccggcctg gtgtatgggc tgaccatgcc gctgcatggt 360
gctcgcggcg aactcggcgc gctgagcctc agcgtggaag cggaaaaccg ggccgaggcc 420
aaccgtttca tggagtcggt cctgccgacc ctgtggatgc tcaaggacta cgcactgcag 480
agcggtgccg gactggcctt cgaacatccg gtcagcaaac cggtggttct gaccagccgg 540
gagaaggaag tgttgcagtg gtgcgccatc ggcaagacca gttgggagat atcggttatc 600
tgcaactgct cggaagccaa tgtgaacttc catatgggaa atattcggcg gaagttcggt 660
gtgacctccc gccgcgtagc ggccattatg gccgttaatt tgggtcttat tactctctga 720
<210> 3
<211> 184
<212> DNA
<213> PesaS
<400> 3
gctcacaaca gtgtaagcgt atccgttatt gtttgatttt caaggaaaaa agaaaacatt 60
caggctccat gctgcttctt ttacttaacg tggacttaac ctgcactata gtacaggcaa 120
gatgatactt aagagtaact tacaatgaat cattcagagg ttacaatggc ttcagttgtt 180
tagc 184
<210> 4
<211> 102
<212> DNA
<213> PesaR-P
<400> 4
ttgtaacctc tgaatgattc attgtaagtt actcttaagt atcatcttgc ctgtactata 60
gtgcaggtta agtccagcct gtactatagt gcaggtggat cc 102
<210> 5
<211> 717
<212> DNA
<213> mCherry
<400> 5
atggtgagca agggcgagga ggataacatg gccatcatca aggagttcat gcgcttcaag 60
gtgcacatgg agggctccgt gaacggccac gagttcgaga tcgagggcga gggcgagggc 120
cgcccctacg agggcaccca gaccgccaag ctgaaggtga ccaagggtgg ccccctgccc 180
ttcgcctggg acatcctgtc ccctcagttc atgtacggct ccaaggccta cgtgaagcac 240
cccgccgaca tccccgacta cttgaagctg tccttccccg agggcttcaa gtgggagcgc 300
gtgatgaact tcgaggacgg cggcgtggtg accgtgaccc aggactcctc cctgcaggac 360
ggcgagttca tctacaaggt gaagctgcgc ggcaccaact tcccctccga cggccccgta 420
atgcagaaga agaccatggg ctgggaggcc tcctccgagc ggatgtaccc cgaggacggc 480
gccctgaagg gcgagatcaa gcagaggctg aagctgaagg acggcggcca ctacgacgct 540
gaggtcaaga ccacctacaa ggccaagaag cccgtgcagc tgcccggcgc ctacaacgtc 600
aacatcaagt ttctagagga catcacctcc cacaacgagg actacaccat cgtggaacag 660
tacgaacgcg ccgagggccg ccactccacc ggcggcatgg acgagctgta caagtaa 717
<210> 6
<211> 720
<212> DNA
<213> EGFP
<400> 6
atggtgagca agggcgagga gctgttcacc ggggtggtgc ccatcctggt cgagctggac 60
ggcgacgtaa acggccacaa gttcagcgtg tccggcgagg gcgagggcga tgccacctac 120
ggcaagctga ccctgaagtt catctgcacc accggcaagc tgcccgtgcc ctggcccacc 180
ctcgtgacca ccctgaccta cggcgtgcag tgcttcagcc gctaccccga ccacatgaag 240
cagcacgact tcttcaagtc cgccatgccc gaaggctacg tccaggagcg caccatcttc 300
ttcaaggacg acggcaacta caagacccgc gccgaggtga agttcgaggg cgacaccctg 360
gtgaaccgca tcgagctgaa gggcatcgac ttcaaggagg acggcaacat cctggggcac 420
aagctggagt acaactacaa cagccacaac gtctatatca tggccgacaa gcagaagaac 480
ggcatcaagg tgaacttcaa gatccgccac aacatcgagg acggcagcgt gcagctcgcc 540
gaccactacc agcagaacac ccccatcggc gacggccccg tgctgctgcc cgacaaccac 600
tacctgagca cccagtccgc cctgagcaaa gaccccaacg agaagcgcga tcacatggtc 660
ctgctggagt tcgtgaccgc cgccgggatc actctcggca tggacgagct gtacaagtaa 720
<210> 7
<211> 888
<212> DNA
<213> motA
<400> 7
gtgcttatct tattaggtta cctggttgtt ctcggtacag ttttcggcgg ttatttgatg 60
accggtggaa gccttggagc actctatcaa cccgctgaac tggtgattat tgccggtgca 120
gggattgggt cgtttatcgt cggcaataat ggcaaagcga ttaaaggcac gctgaaggcg 180
ctgccgttgc tgtttcgtcg ctccaaatac accaaagcaa tgtatatgga tctgctggct 240
ctgctttatc ggttgatggc gaaatcgcgg cagatgggga tgttttcgct ggaacgtgat 300
attgaaaatc cccgtgagag cgagatcttc gccagctacc cacgcatcct cgcggatagc 360
gtcatgcttg attttatcgt cgattatctg cgcctgatta tcagcggtca catgaacacc 420
ttcgaaatcg aagctctgat ggatgaagag attgagacgc acgaaagcga ggcagaagtc 480
ccggcgaaca gtctggcgct ggtcggggac tcacttccgg cgtttggtat tgttgcggct 540
gtaatggggg tcgttcacgc gttaggttca gccgatcgtc ctgccgccga gctgggtgcg 600
cttatcgcac atgcgatggt ggggactttc ctcggcattt tattggctta cggatttatt 660
tccccattag cgactgtttt acgtcagaaa agcgccgaaa ccagcaaaat gatgcagtgc 720
gtcaaagtca ctctgctttc taatctgaac ggttacgcac cgcctatcgc cgttgagttt 780
ggtcgcaaaa cgctctattc cagcgaacgt ccgtcgttta ttgaactgga agagcatgtg 840
cgtgcggtga aaaatccgca acaacagacg acaaccgagg aagcatga 888
<210> 8
<211> 6944
<212> DNA
<213> pUC19-PJ23119-MCS-esaI/R
<400> 8
gcgcccaata cgcaaaccgc ctctccccgc gcgttggccg attcattaat gcagctggca 60
cgacaggttt cccgactgga aagcgggcag tgagcgcaac gcaattaatg tgagttagct 120
cactcattag gcaccccagg cttgacagct agctcagtcc taggtataat actagttttc 180
acacaggaaa cagctatgac catgattacg ccaagcttaa gaaaccaatt gtccatattg 240
catcagacat tgccgtcact gcgtctttta ctggcacttc tcgctaacca aaccggtaac 300
cccgcttatt aaaagcattc tgtaacaaag cgggaccaaa gccatgacaa aaacgcgtaa 360
caaaagtgtc tataatcacg gcagaaaagt ccacattgat tatttgcacg gcgtcacact 420
ttgctatgcc atagcatttt tatccataag attagcggat cctacctgac gctttttatc 480
gcaactctct actgtttctc catgtcgaca tgatcgtaca aattggtcgg cgcgaagagt 540
tcgataaaaa actgctgggc gagatgcaca agttgcgtgc tcaagtgttc aaggagcgca 600
aaggctggga cgttagtgtc atcgacgaga tggaaatcga tggttatgac gcactcagtc 660
cttattacat gttgatccag gaagatactc ctgaagccca ggttttcggt tgctggcgaa 720
ttctcgatac cactggcccc tacatgctga agaacacctt cccggagctt ctgcacggca 780
aggaagcgcc ttgctcgccg cacatctggg aactcagccg tttcgccatc aactctggac 840
agaaaggctc gctgggcttt tccgactgta cgctggaggc gatgcgcgcg ctggcccgct 900
acagcctgca gaacgacatc cagacgctgg tgacggtaac caccgtaggc gtggagaaga 960
tgatgatccg tgccggcctg gacgtatcgc gcttcggtcc gcacctgaag atcggcatcg 1020
agcgcgcggt ggccttgcgc atcgaactca atgccaagac ccagatcgcg ctttacgggg 1080
gagtgctggt ggaacagcga ctggcggttt catgataatg tgagttagct cactcattag 1140
gcaccccagg cttgacagct agctcagtcc taggtataat actagtatgg ccttggttga 1200
cggttttctt gagctggaac gctcaagtgg aaaattggag tggagcgcca tcctgcagaa 1260
gatggcgagc gaccttggat tctcgaagat cctgttcggc ctgttgccta aggacagcca 1320
ggactacgag aacgccttca tcgtcggcaa ctacccggcc gcctggcgcg agcattacga 1380
ccgggctggc tacgcgcggg tcgacccgac ggtcagtcac tgtacccaga gcgtactgcc 1440
gattttctgg gaaccgtcca tctaccagac gcgaaagcag cacgagttct tcgaggaagc 1500
ctcggccgcc ggcctggtgt atgggctgac catgccgctg catggtgctc gcggcgaact 1560
cggcgcgctg agcctcagcg tggaagcgga aaaccgggcc gaggccaacc gtttcatgga 1620
gtcggtcctg ccgaccctgt ggatgctcaa ggactacgca ctgcagagcg gtgccggact 1680
ggccttcgaa catccggtca gcaaaccggt ggttctgacc agccgggaga aggaagtgtt 1740
gcagtggtgc gccatcggca agaccagttg ggagatatcg gttatctgca actgctcgga 1800
agccaatgtg aacttccata tgggaaatat tcggcggaag ttcggtgtga cctcccgccg 1860
cgtagcggcc attatggccg ttaatttggg tcttattact ctctgagcat gcgctcacaa 1920
cagtgtaagc gtatccgtta ttgtttgatt ttcaaggaaa aaagaaaaca ttcaggctcc 1980
atgctgcttc ttttacttaa cgtggactta acctgcacta tagtacaggc aagatgatac 2040
ttaagagtaa cttacaatga atcattcaga ggttacaatg gcttcagttg tttagcgtcg 2100
acgtgcttat cttattaggt tacctggttg ttctcggtac agttttcggc ggttatttga 2160
tgaccggtgg aagccttgga gcactctatc aacccgctga actggtgatt attgccggtg 2220
cagggattgg gtcgtttatc gtcggcaata atggcaaagc gattaaaggc acgctgaagg 2280
cgctgccgtt gctgtttcgt cgctccaaat acaccaaagc aatgtatatg gatctgctgg 2340
ctctgcttta tcggttgatg gcgaaatcgc ggcagatggg gatgttttcg ctggaacgtg 2400
atattgaaaa tccccgtgag agcgagatct tcgccagcta cccacgcatc ctcgcggata 2460
gcgtcatgct tgattttatc gtcgattatc tgcgcctgat tatcagcggt cacatgaaca 2520
ccttcgaaat cgaagctctg atggatgaag agattgagac gcacgaaagc gaggcagaag 2580
tcccggcgaa cagtctggcg ctggtcgggg actcacttcc ggcgtttggt attgttgcgg 2640
ctgtaatggg ggtcgttcac gcgttaggtt cagccgatcg tcctgccgcc gagctgggtg 2700
cgcttatcgc acatgcgatg gtggggactt tcctcggcat tttattggct tacggattta 2760
tttccccatt agcgactgtt ttacgtcaga aaagcgccga aaccagcaaa atgatgcagt 2820
gcgtcaaagt cactctgctt tctaatctga acggttacgc accgcctatc gccgttgagt 2880
ttggtcgcaa aacgctctat tccagcgaac gtccgtcgtt tattgaactg gaagagcatg 2940
tgcgtgcggt gaaaaatccg caacaacaga cgacaaccga ggaagcatga atggtgagca 3000
agggcgagga ggataacatg gccatcatca aggagttcat gcgcttcaag gtgcacatgg 3060
agggctccgt gaacggccac gagttcgaga tcgagggcga gggcgagggc cgcccctacg 3120
agggcaccca gaccgccaag ctgaaggtga ccaagggtgg ccccctgccc ttcgcctggg 3180
acatcctgtc ccctcagttc atgtacggct ccaaggccta cgtgaagcac cccgccgaca 3240
tccccgacta cttgaagctg tccttccccg agggcttcaa gtgggagcgc gtgatgaact 3300
tcgaggacgg cggcgtggtg accgtgaccc aggactcctc cctgcaggac ggcgagttca 3360
tctacaaggt gaagctgcgc ggcaccaact tcccctccga cggccccgta atgcagaaga 3420
agaccatggg ctgggaggcc tcctccgagc ggatgtaccc cgaggacggc gccctgaagg 3480
gcgagatcaa gcagaggctg aagctgaagg acggcggcca ctacgacgct gaggtcaaga 3540
ccacctacaa ggccaagaag cccgtgcagc tgcccggcgc ctacaacgtc aacatcaagt 3600
ttctagagga catcacctcc cacaacgagg actacaccat cgtggaacag tacgaacgcg 3660
ccgagggccg ccactccacc ggcggcatgg acgagctgta caagtaattg taacctctga 3720
atgattcatt gtaagttact cttaagtatc atcttgcctg tactatagtg caggttaagt 3780
ccagcctgta ctatagtgca ggtggatccc tcgagatggt gagcaagggc gaggagctgt 3840
tcaccggggt ggtgcccatc ctggtcgagc tggacggcga cgtaaacggc cacaagttca 3900
gcgtgtccgg cgagggcgag ggcgatgcca cctacggcaa gctgaccctg aagttcatct 3960
gcaccaccgg caagctgccc gtgccctggc ccaccctcgt gaccaccctg acctacggcg 4020
tgcagtgctt cagccgctac cccgaccaca tgaagcagca cgacttcttc aagtccgcca 4080
tgcccgaagg ctacgtccag gagcgcacca tcttcttcaa ggacgacggc aactacaaga 4140
cccgcgccga ggtgaagttc gagggcgaca ccctggtgaa ccgcatcgag ctgaagggca 4200
tcgacttcaa ggaggacggc aacatcctgg ggcacaagct ggagtacaac tacaacagcc 4260
acaacgtcta tatcatggcc gacaagcaga agaacggcat caaggtgaac ttcaagatcc 4320
gccacaacat cgaggacggc agcgtgcagc tcgccgacca ctaccagcag aacaccccca 4380
tcggcgacgg ccccgtgctg ctgcccgaca accactacct gagcacccag tccgccctga 4440
gcaaagaccc caacgagaag cgcgatcaca tggtcctgct ggagttcgtg accgccgccg 4500
ggatcactct cggcatggac gagctgtaca agtaagagct cgaattcact ggccgtcgtt 4560
ttacaacgtc gtgactggga aaaccctggc gttacccaac ttaatcgcct tgcagcacat 4620
ccccctttcg ccagctggcg taatagcgaa gaggcccgca ccgatcgccc ttcccaacag 4680
ttgcgcagcc tgaatggcga atggcgcctg atgcggtatt ttctccttac gcatctgtgc 4740
ggtatttcac accgcatatg gtgcactctc agtacaatct gctctgatgc cgcatagtta 4800
agccagcccc gacacccgcc aacacccgct gacgcgccct gacgggcttg tctgctcccg 4860
gcatccgctt acagacaagc tgtgaccgtc tccgggagct gcatgtgtca gaggttttca 4920
ccgtcatcac cgaaacgcgc gagacgaaag ggcctcgtga tacgcctatt tttataggtt 4980
aatgtcatga taataatggt ttcttagacg tcaggtggca cttttcgggg aaatgtgcgc 5040
ggaaccccta tttgtttatt tttctaaata cattcaaata tgtatccgct catgagacaa 5100
taaccctgat aaatgcttca ataatattga aaaaggaaga gtatgagtat tcaacatttc 5160
cgtgtcgccc ttattccctt ttttgcggca ttttgccttc ctgtttttgc tcacccagaa 5220
acgctggtga aagtaaaaga tgctgaagat cagttgggtg cacgagtggg ttacatcgaa 5280
ctggatctca acagcggtaa gatccttgag agttttcgcc ccgaagaacg ttttccaatg 5340
atgagcactt ttaaagttct gctatgtggc gcggtattat cccgtattga cgccgggcaa 5400
gagcaactcg gtcgccgcat acactattct cagaatgact tggttgagta ctcaccagtc 5460
acagaaaagc atcttacgga tggcatgaca gtaagagaat tatgcagtgc tgccataacc 5520
atgagtgata acactgcggc caacttactt ctgacaacga tcggaggacc gaaggagcta 5580
accgcttttt tgcacaacat gggggatcat gtaactcgcc ttgatcgttg ggaaccggag 5640
ctgaatgaag ccataccaaa cgacgagcgt gacaccacga tgcctgtagc aatggcaaca 5700
acgttgcgca aactattaac tggcgaacta cttactctag cttcccggca acaattaata 5760
gactggatgg aggcggataa agttgcagga ccacttctgc gctcggccct tccggctggc 5820
tggtttattg ctgataaatc tggagccggt gagcgtgggt ctcgcggtat cattgcagca 5880
ctggggccag atggtaagcc ctcccgtatc gtagttatct acacgacggg gagtcaggca 5940
actatggatg aacgaaatag acagatcgct gagataggtg cctcactgat taagcattgg 6000
taactgtcag accaagttta ctcatatata ctttagattg atttaaaact tcatttttaa 6060
tttaaaagga tctaggtgaa gatccttttt gataatctca tgaccaaaat cccttaacgt 6120
gagttttcgt tccactgagc gtcagacccc gtagaaaaga tcaaaggatc ttcttgagat 6180
cctttttttc tgcgcgtaat ctgctgcttg caaacaaaaa aaccaccgct accagcggtg 6240
gtttgtttgc cggatcaaga gctaccaact ctttttccga aggtaactgg cttcagcaga 6300
gcgcagatac caaatactgt tcttctagtg tagccgtagt taggccacca cttcaagaac 6360
tctgtagcac cgcctacata cctcgctctg ctaatcctgt taccagtggc tgctgccagt 6420
ggcgataagt cgtgtcttac cgggttggac tcaagacgat agttaccgga taaggcgcag 6480
cggtcgggct gaacgggggg ttcgtgcaca cagcccagct tggagcgaac gacctacacc 6540
gaactgagat acctacagcg tgagctatga gaaagcgcca cgcttcccga agggagaaag 6600
gcggacaggt atccggtaag cggcagggtc ggaacaggag agcgcacgag ggagcttcca 6660
gggggaaacg cctggtatct ttatagtcct gtcgggtttc gccacctctg acttgagcgt 6720
cgatttttgt gatgctcgtc aggggggcgg agcctatgga aaaacgccag caacgcggcc 6780
tttttacggt tcctggcctt ttgctggcct tttgctcaca tgttctttcc tgcgttatcc 6840
cctgattctg tggataaccg tattaccgcc tttgagtgag ctgataccgc tcgccgcagc 6900
cgaacgaccg agcgcagcga gtcagtgagc gaggaagcgg aaga 6944
<210> 9
<211> 52
<212> DNA
<213> motA-F
<400> 9
caatggcttc agttgtttag cgtcgacgtg cttatcttat taggttacct gg 52
<210> 10
<211> 47
<212> DNA
<213> motA-R
<400> 10
atcctcctcg cccttgctca ccattcatgc ttcctcggtt gtcgtct 47
<210> 11
<211> 50
<212> DNA
<213> esaI-F
<400> 11
gcaactctct actgtttctc catgtcgaca tgatcgtaca aattggtcgg 50
<210> 12
<211> 65
<212> DNA
<213> esaI-R
<400> 12
gtcaaccaag gccatactag tattatacct aggactgagc tagctgtcaa tcatgaaacc 60
gccag 65
<210> 13
<211> 65
<212> DNA
<213> esaR-F
<400> 13
ctggcggttt catgattgac agctagctca gtcctaggta taatactagt atggccttgg 60
ttgac 65
<210> 14
<211> 37
<212> DNA
<213> esaR-R
<400> 14
gcatgctcag agagtaataa gacccaaatt aacggcc 37
<210> 15
<211> 46
<212> DNA
<213> PesaS-F
<400> 15
tgggtcttat tactctctga gcatgcgctc acaacagtgt aagcgt 46
<210> 16
<211> 47
<212> DNA
<213> PesaS-R
<400> 16
agggtaataa ctcgtttcat gtcgacgcta aacaactgaa gccattg 47
<210> 17
<211> 42
<212> DNA
<213> PesaR-P-F
<400> 17
ctacaacgtc aacatcaagt ttctagagga catcacctcc ca 42
<210> 18
<211> 52
<212> DNA
<213> PesaR-P-R
<400> 18
tctcggcatg gacgagctgt acaagtaact cgagggatcc acctgcacta ta 52
<210> 19
<211> 47
<212> DNA
<213> mcherry-F
<400> 19
gcgtgacttt tgtttatcaa taaatggtga gcaagggcga ggaggat 47
<210> 20
<211> 26
<212> DNA
<213> mcherry-R
<400> 20
tctagattac ttgtacagct cgtcca 26
<210> 21
<211> 47
<212> DNA
<213> EGFP-F
<400> 21
agaagcagcg gatccctcga gatggtgagc aagggcgagg agctgtt 47
<210> 22
<211> 50
<212> DNA
<213> EGFP-R
<400> 22
cgacggccag tgaattcgag ctcttacttg tacagctcgt ccatgccgag 50
<210> 23
<211> 1287
<212> DNA
<213> thrC
<400> 23
atgaaactct acaatctgaa agatcacaac gagcaggtca gctttgcgca agccgtaacc 60
caggggttgg gcaaaaatca ggggctgttt tttccgcacg acctgccgga attcagcctg 120
actgaaattg atgagatgct gaagctggat tttgtcaccc gcagtgcgaa gatcctctcg 180
gcgtttattg gtgatgaaat cccacaggaa atcctggaag agcgcgtgcg cgcggcgttt 240
gccttcccgg ctccggtcgc caatgttgaa agcgatgtcg gttgtctgga attgttccac 300
gggccaacgc tggcatttaa agatttcggc ggtcgcttta tggcacaaat gctgacccat 360
attgcgggtg ataagccagt gaccattctg accgcgacct ccggtgatac cggagcggca 420
gtggctcatg ctttctacgg tttaccgaat gtgaaagtgg ttatcctcta tccacgaggc 480
aaaatcagtc cactgcaaga aaaactgttc tgtacattgg gcggcaatat cgaaactgtt 540
gccatcgacg gcgatttcga tgcctgtcag gcgctggtga agcaggcgtt tgatgatgaa 600
gaactgaaag tggcgctagg gttaaactcg gctaactcga ttaacatcag ccgtttgctg 660
gcgcagattt gctactactt tgaagctgtt gcgcagctgc cgcaggagac gcgcaaccag 720
ctggttgtct cggtgccaag cggaaacttc ggcgatttga cggcgggtct gctggcgaag 780
tcactcggtc tgccggtgaa acgttttatt gctgcgacca acgtgaacga taccgtgcca 840
cgtttcctgc acgacggtca gtggtcaccc aaagcgactc aggcgacgtt atccaacgcg 900
atggacgtga gtcagccgaa caactggccg cgtgtggaag agttgttccg ccgcaaaatc 960
tggcaactga aagagctggg ttatgcagcc gtggatgatg aaaccacgca acagacaatg 1020
cgtgagttaa aagaactggg ctacacttcg gagccgcacg ctgccgtagc ttatcgtgcg 1080
ctgcgtgatc agttgaatcc aggcgaatat ggcttgttcc tcggcaccgc gcatccggcg 1140
aaatttaaag agagcgtgga agcgattctc ggtgaaacgt tggatctgcc aaaagagctg 1200
gcagaacgtg ctgatttacc cttgctttca cataatctgc ccgccgattt tgctgcgttg 1260
cgtaaattga tgatgaatca tcagtaa 1287
Claims (10)
1. An escherichia coli genetic engineering bacterium is characterized in that pUC19-PJ23119-MCS plasmid containing esaI/R system is introduced into escherichia coli W1688 and combined with motor gene motA.
2. The engineered escherichia coli strain of claim 1, wherein the gene contained in the esaI/R system is a transcription regulatory factor having a nucleotide sequence as shown in SEQ ID No.1 and SEQ ID No.2, respectively: esaI, esaR; the nucleotide sequences of the promoter are respectively shown as SEQ ID NO.3 and SEQ ID NO. 4: p is esaS 、P esaR-P (ii) a The nucleotide sequences of the reporter genes are respectively shown as SEQ ID NO.5 and SEQ ID NO. 6: red fluorescent protein mCherry, green fluorescent protein EGFP.
3. The engineered escherichia coli strain as claimed in claim 1, wherein the nucleotide sequence of the motor gene motA is represented by SEQ ID No. 7.
4. The method for constructing the Escherichia coli genetically engineered bacterium of any one of claims 1 to 3, comprising the steps of:
(1) amplifying to obtain esaI and esaR genes by taking pseudomonas aeruginosa genome DNA as a template; the gene P is synthesized by general biosynthesis esaS 、P esaR-P The PUC19 plasmid is used as a template to obtain P through amplification esaS 、P esaR-P A gene; amplifying by taking a plasmid pET28a-mCherry as a template to obtain an mCheerry gene; amplifying by taking the plasmid pET-28a-EGFP as a template to obtain an EGFP gene;
(2) taking the fragment obtained in the step (1) as a template, and carrying out overlap PCR amplification to obtain an esaI + esaR fragment and P esaS + motA + mCherry fragment, P esaR-P + an EGFP fragment;
(3) cloning the gene fragment obtained in the step (2) between Hind III and Sac I restriction sites of plasmid pUC19-PJ23119-MCS to obtain recombinant plasmid pUC19-PJ23119-MCS-esaI/R, wherein the nucleotide sequence of the recombinant plasmid is shown as SEQ ID NO. 8;
(4) transforming the recombinant plasmid obtained in the step (3) into an escherichia coli T1 competence, and extracting, purifying and recovering the recombinant plasmid from escherichia coli T1;
(5) and (3) transforming the recombinant plasmid extracted in the step (4) into the competence of Escherichia coli W1688 to obtain the Escherichia coli genetic engineering bacteria.
5. The method according to claim 4, wherein in step (1), primers for amplifying esaI and esaR genes are esaI-F, esaI-R, esaR-F, esaR-R with nucleotide sequences shown in SEQ ID NO.11, SEQ ID NO.12, SEQ ID NO.13 and SEQ ID NO.14, respectively.
6. The method of claim 4, wherein in step (1), P is amplified esaS 、P esaR-P The primers of the gene are P with nucleotide sequences shown as SEQ ID NO.15, SEQ ID NO.16, SEQ ID NO.17 and SEQ ID NO.18 respectively esaS -F、P esaS -R、P esaR-P -F、P esaR-P -R。
7. The method of claim 4, wherein in step (1), primers for amplifying mCherry and EGFP genes are mCherry-F, mCherry-R, EGFP-F, EGFP-R with nucleotide sequences shown in SEQ ID NO.19, SEQ ID NO.20, SEQ ID NO.21 and SEQ ID NO.22, respectively.
8. Use of the genetically engineered Escherichia coli of any one of claims 1 to 3 for producing L-threonine.
9. The use of claim 8, wherein threonine synthetase thrC with the nucleotide sequence shown in SEQ ID NO.23 is substituted to the position of EGFP gene in the genetically engineered Escherichia coli, and the genetically engineered Escherichia coli is inoculated into a fermentation medium to produce xylanase through fermentation.
10. The use of claim 9, wherein the fermentation medium comprises 30g/L glucose, 0.8g/L sodium chloride, 20-22g/L ammonium sulfate, 2g/L anhydrous potassium dihydrogen phosphate, 0.8g/L magnesium sulfate heptahydrate, 0.02g/L manganese sulfate pentahydrate, 0.02g/L iron sulfate heptahydrate, 10.002g/L vitamin B, 1g/L yeast powder and 15-30g/L calcium carbonate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210712627.4A CN114958705A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210712627.4A CN114958705A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114958705A true CN114958705A (en) | 2022-08-30 |
Family
ID=82964666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210712627.4A Pending CN114958705A (en) | 2022-06-22 | 2022-06-22 | Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114958705A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140162325A1 (en) * | 2011-08-18 | 2014-06-12 | Ajinomoto Co., Inc. | Method for Producing an L-Amino Acid Using a Bacterium of the Family Enterobacteriaceae Having Enhanced Expression of the Flagella Formation and Motility Cascade Genes |
CN110527693A (en) * | 2019-06-28 | 2019-12-03 | 南京农业大学 | It is a kind of based on the gene switching system of pseudomonas aeruginosa intervention school-based and its application |
-
2022
- 2022-06-22 CN CN202210712627.4A patent/CN114958705A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140162325A1 (en) * | 2011-08-18 | 2014-06-12 | Ajinomoto Co., Inc. | Method for Producing an L-Amino Acid Using a Bacterium of the Family Enterobacteriaceae Having Enhanced Expression of the Flagella Formation and Motility Cascade Genes |
CN110527693A (en) * | 2019-06-28 | 2019-12-03 | 南京农业大学 | It is a kind of based on the gene switching system of pseudomonas aeruginosa intervention school-based and its application |
Non-Patent Citations (2)
Title |
---|
JAYAMARY DIVYA RAVICHANDAR 等: ""Transcriptional control of motility enables directional movement of Escherichia coli in a signal gradient"", 《SCIENTIFIC REPORTS》, vol. 7, pages 2 * |
THAKKAR,M.,等: ""NC_CP080399"", NCBI GENBANK * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040253704A1 (en) | Surface expression vectors having pgsbca the gene coding poly-gamma-glutamate synthetase, and a method for expression of target protein at the surface of microorganism using the vector | |
CN108977454A (en) | A kind of Escherichia coli synthesis squalene plasmid pTsqs and its preparation and application | |
CN114072520A (en) | Method and kit for detecting target nucleic acid fragment | |
CN112501101B (en) | High-yield strain of natural herbicide thaxtomins as well as preparation method and application thereof | |
CN106497960A (en) | A kind of efficient shuttle plasmid for Escherichia coli riemerella anatipestifer | |
CN111187785B (en) | Cloning expression and application of serpentis grass tryptophan decarboxylase gene OpTDC2 | |
CN113637623A (en) | Bacillus subtilis for increasing yield of 2' -fucosyllactose and construction method and application thereof | |
CN108949599A (en) | A kind of production alpha, beta-lonone genetic engineering bacterium and its construction method and application | |
CN110628806B (en) | High-yield beta-ionone genetic engineering bacterium and construction method and application thereof | |
CN114958705A (en) | Method for improving immobilized fermentation of escherichia coli by applying flagellin motA to quorum sensing dynamic regulation and control system | |
CN106520820B (en) | A method of plasma pro-brain natriuretic peptide levels epitope is prepared using bacillus brevis | |
CN101948866A (en) | Construction of bacillus subtilis integrated vector capable of being cloned by using homologous recombination and application thereof | |
CN114350698B (en) | Human recombinant arginase I production strain and construction method thereof | |
CN114196712B (en) | Method for producing L-ornithine by immobilized enzyme method | |
CN114214353B (en) | Method for producing human recombinant arginase I by fermentation | |
CN114350721B (en) | Method for producing L-ornithine by microbial enzyme method | |
CN114085861B (en) | Arginine decarboxylase producing strain and construction method thereof | |
CN108949795B (en) | Plasmid pCDSP for increasing squalene content in escherichia coli and preparation and use methods thereof | |
CN112831524B (en) | Artificially modified recombinant adenovirus vector, virus packaged by same and application thereof | |
CN115029378B (en) | Method for creating flower-spot ornamental poplar by PtrDJ1C gene | |
KR20190027616A (en) | Recombinant transition vector for enhancement of foreign protein exression | |
CN108085325B (en) | Glyphosate-resistant gene and cultivation method of transgenic glyphosate-resistant tobacco | |
CN114839382A (en) | Method for establishing bimolecular fluorescence complementary system based on red fluorescent protein in yeast | |
KR101411456B1 (en) | Soluble overexpression and purification method of biological active recombinant human BMP7 in Escherichia coli | |
CN114058651A (en) | Preparation method of agmatine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |